No Data
Hsiang Sheng Healthcare: Report for the third quarter of 2024
Xiang Sheng Medical Report for the Third Quarter of 2024
Chison Medical Technologies (688358.SH): Plans to launch a restricted stock incentive plan for 2024.
On September 30, Chison Medical Technologies (688358.SH) announced the 2024 restricted stock incentive plan, proposing to grant 593,000 restricted stocks to incentive recipients, accounting for approximately 0.53% of the total share capital of 112,124,537 shares at the time of the announcement of this incentive plan draft. Among them, the initial grant is 475,500 shares, accounting for about 0.42% of the total share capital of 112,124,537 shares at the time of the announcement of this incentive plan draft. The initial grant portion accounts for 80.19% of the total equity to be granted; reserving 117,500 shares, accounting for approximately
Chison Medical Technologies (688358): Performance under pressure, maintaining a high proportion of research and development investment.
The company's performance in the first half of 2024 is under pressure, with a larger decline in profit than in revenue. The company achieved revenue of 0.248 billion yuan (-16.47%) and net income attributable to shareholders of 0.081 billion yuan (-27.35%) in the first half of 2024, after deducting non-recurring items.
Kosei Medical 2024 Semi-Annual Report
Summary of the 2024 Semi-Annual Report of Xiang Sheng Medical
No Data
No Data